- Home
- ACT vs TXG Comparison
ACT vs TXG Comparison
Compare ACT & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACT | TXG |
|---|---|---|
| Founded | 1981 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.6B |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ACT | TXG |
|---|---|---|
| Price | $47.53 | $49.40 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 15 |
| Target Price | ★ $44.25 | $20.25 |
| AVG Volume (30 Days) | 331.0K | ★ 2.9M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.90% | N/A |
| EPS Growth | 3.43 | ★ 76.97 |
| EPS | ★ 1.18 | N/A |
| Revenue | ★ $1,235,827,000.00 | $245,893,000.00 |
| Revenue This Year | $4.06 | N/A |
| Revenue Next Year | $2.33 | $7.33 |
| P/E Ratio | $40.97 | ★ N/A |
| Revenue Growth | 2.83 | ★ 68.06 |
| 52 Week Low | $34.64 | $11.17 |
| 52 Week High | $48.79 | $49.50 |
Technical Indicators
Market Signals| Indicator | ACT | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 71.75 | 64.02 |
| Support Level | $39.78 | $16.11 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 1.03 | 2.69 |
| MACD | 0.16 | -0.23 |
| Stochastic Oscillator | 91.12 | 60.55 |
Price Performance
Historical ComparisonAbout ACT Enact Holdings Inc.
Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The company operates in a single reportable segment namely Mortgage Insurance The principal mortgage insurance customers are originators of residential mortgage loans that determines the mortgage insurer or insurers to be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).